Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer

Clinical trial NCT05086614 · RECRUITING

Trial details

NCT number: NCT05086614
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Stage II Colorectal Cancer Stage III Colorectal Cancer

Start date: 2021-04-01
Primary completion: 2027-03-31
Enrollment: 2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.